This compound is a pharmaceutical intermediate used in the synthesis of efavirenz, a non-nucleoside reverse transcriptase inhibitor. It is characterized by the presence of an aromatic ring, an alcohol group, and a carbamate ester moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Efavirenz amino alcohol ethyl carbamate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-(Trifluoromethyl)benzenepropanal
pharmaceutical intermediate
Abiraterone Impurity N1
pharmaceutical intermediate
6-Bromopicolinic acid
pharmaceutical intermediate
Ethyl 6-bromopyridine-2-carboxylate
pharmaceutical intermediate
Efavirenz aminoalcohol
pharmaceutical intermediate
ethyl N-[4-chloro-2-[(2S)-4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl]phenyl]carbamate
BZIKLWWRUOKZMC-HNNXBMFYSA-N
CCOC(=O)NC1=C(C=C(C=C1)Cl)[C@@](C#CC2CC2)(C(F)(F)F)O
Sourcing Efavirenz amino alcohol ethyl carbamate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.